feed,title,long_url,short_url
Benzinga,AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review,https://benzinga.com/general/biotech/23/03/31513126/astrazeneca-ionis-partnered-rare-disease-drug-data-shows-sustained-benefit-drug-under-fda-review,https://da.gd/tfczRN
